Investment Objective The investment seeks long-term total return. The fund invests primarily in equity securities- principally common and preferred stocks- of small cap companies. The adviser defines small cap companies as those with market …
Hal Mintz’s Sabby Capital also made a $0.3 million investment in the stock during the quarter. The other funds with brand new DRNA positions are Behzad Aghazadeh’s venBio Select Advisor and Peter Muller’s PDT Partners.